Dispensed: An Alzheimer's drug flameout, a new depression drug, and a Stanford professor who saw through Elizabeth Holmes early on

OK show of hands, how many of you have finally hit your limit on Theranos/Elizabeth Holmes content? I think across the newsroom, we pulled togetherin the last week and a half . I'd definitely recommend checking them all out if you can't get enough of the story. Up next in the saga: awaiting the trial. There's a court date scheduled for late April, I'll be sure to keep you posted as the trial starts to get underway.

Two months ago, Apple CEO Tim Cook said his company's"greatest contribution to mankind" would be in health. OK, I know I said we were almost done chatting about Theranos until the trial gets underway, but I couldn't help slipping one more interview I posted this week — this one with Dr. Phyllis Gardner, a professor at Stanford who shot down one of Elizabeth Holmes' early ideas and watched as the entire rise and fall of the company unfolded. Favorite quotes include:"I was just barfing all over the place.

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

A new drug based on ketamine could help treat depressionMost antidepressants take weeks or months to take effect. A ketamine-based drug takes only hours That’s true ketamine and benzodiazepines are way better then their bad reputation That'll make them grow... But a lot... antidepressant... A new drug addiction eh?
Source: TheEconomist - 🏆 6. / 92 Read more »

Biogen heads for the worst day in a decade after ending trial for blockbuster Alzheimer's drugShares of Biogen plummeted Thursday after the company halted the trial of Alzheimer's disease drug aducanumab. Literally no one expected it to be a blockbuster. No quick fix for Trump
Source: CNBC - 🏆 12. / 72 Read more »